» Articles » PMID: 32901082

Immune Suppressed Tumor Microenvironment by Exosomes Derived from Gastric Cancer Cells Via Modulating Immune Functions

Overview
Journal Sci Rep
Specialty Science
Date 2020 Sep 9
PMID 32901082
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Gastric cancer is one of the leading causes of cancer-related death due to late diagnosis with high metastatic frequency. In this study, the impact of tumor secreted exosomes on immune function in the tumor environment was investigated using exosomes isolated from gastric cancer cell lines MKN-28, MKN-45, and SGC-7901. Results show that exosomes derived from all of these cell lines changed the gene expression and cytokine secretion levels of CD8 T cells. They also block cell cycle progression, induced apoptosis in CD8 T cells. Image analysis of fluorescent labeled exosomes derived from three cell lines injected systemically into C57BL/6 mice revealed these exosomes primarily localize to the lungs. We further showed exosomes were mainly taken up by natural killer cells and macrophages in the lung. After long-term exposure to inject exosomes from MKN-45 cells, mice developed an immunosuppressive tumor microenvironment in the lung with increased frequency of effector memory CD4 T and MDSC, decreased CD8 T cell and NK frequency. This immune suppressive environment promotes gastric cancer lung metastasis. Lung metastasis sites developed after mice were exposed to exosomes isolated from all three gastric cancer cell lines when the mice were injected with MFC cells. Results suggest that exosomes derived from gastric cancer cells (especially MKN-45 and MKN-28) changed CD8 T cell gene expression and cytokine secretion patterns to create an immunosuppressive condition for metastatic niche formation in the lung. Overall, this study provides new insights into how gastric cancer derived exosomes modulate the immune response to promote lung tumor metastasis.

Citing Articles

Exosomes play a crucial role in remodeling the tumor microenvironment and in the treatment of gastric cancer.

Tang L, Zhang W, Qi T, Jiang Z, Tang D Cell Commun Signal. 2025; 23(1):82.

PMID: 39948541 PMC: 11827163. DOI: 10.1186/s12964-024-02009-7.


Research trends and hotspots in gastric carcinoma associated exosome: a bibliometric analysis.

Liu C, Guo H, Jin F Front Oncol. 2024; 14:1457346.

PMID: 39703839 PMC: 11655325. DOI: 10.3389/fonc.2024.1457346.


The role and clinical applications of exosomes in cancer drug resistance.

Pan W, Miao Q, Yin W, Li X, Ye W, Zhang D Cancer Drug Resist. 2024; 7:43.

PMID: 39624083 PMC: 11609145. DOI: 10.20517/cdr.2024.97.


Exosomes are the mediators between the tumor microenvironment and prostate cancer (Review).

Wu Y, Wang X, Zeng Y, Liu X Exp Ther Med. 2024; 28(6):439.

PMID: 39355518 PMC: 11443591. DOI: 10.3892/etm.2024.12728.


Vascularized platforms for investigating cell communication via extracellular vesicles.

Kim J, Ro J, Cho Y Biomicrofluidics. 2024; 18(5):051504.

PMID: 39323481 PMC: 11421861. DOI: 10.1063/5.0220840.


References
1.
Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

2.
Siegel R, Miller K, Jemal A . Cancer statistics, 2020. CA Cancer J Clin. 2020; 70(1):7-30. DOI: 10.3322/caac.21590. View

3.
Park J, von Karsa L, Herrero R . Prevention strategies for gastric cancer: a global perspective. Clin Endosc. 2014; 47(6):478-89. PMC: 4260094. DOI: 10.5946/ce.2014.47.6.478. View

4.
Loo J, Scherl A, Nguyen A, Man F, Weinberg E, Zeng Z . Extracellular metabolic energetics can promote cancer progression. Cell. 2015; 160(3):393-406. PMC: 4312495. DOI: 10.1016/j.cell.2014.12.018. View

5.
Sun Z, Yang S, Zhou Q, Wang G, Song J, Li Z . Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment. Mol Cancer. 2018; 17(1):82. PMC: 5909226. DOI: 10.1186/s12943-018-0831-z. View